Ethos Cannabis, Thomas Jefferson University to Co-Host Pennsylvania Medical Marijuana Education & Research Summit

*PHILADELPHIA —* Ethos Cannabis partnered with Thomas Jefferson University
to host the Pennsylvania Medical Marijuana Education & Research Summit on
Friday, September 5, 2025, at Jefferson’s Alumni Hall Atrium from 8 am to
3:30 pm ET.

With more than 425,000 registered medical marijuana patients and a growing
push toward adult-use legalization, Pennsylvania is at a pivotal moment in
its cannabis evolution. Positioned as one of the nation’s most established
medical-only cannabis markets, the Commonwealth now faces a unique
opportunity to set the national standard for evidence-based cannabis
policy, clinical research, and patient-first care.

To drive this conversation forward, the Pennsylvania Medical Marijuana
Education & Research Summit aims to bridge the gap between public health,
science, and policy, bringing together policy experts, researchers,
clinicians, regulators, and industry experts to discuss how cannabis can
safely and effectively meet the evolving needs of Pennsylvania’s patients
and communities.

The summit will feature expert panels, educational sessions, and networking
focused on the future of cannabis science and patient care. The summit will
feature a keynote talk from Meghna Patel, Deputy Secretary of Policy and
Planning at the Office of Governor Josh Shapiro, and talks from the
Philadelphia Department of Public Health, Cannabis Control Commission,
Drexel University, Thomas Jefferson University, Ethos Cannabis, and more.

Panels include:

- Keystone Shift – The Opioid Epidemic and the Role of Cannabis in Harm
Reduction
- Moderator: Allison Herens (Philadelphia Department of Public Health)

Panelists:

- Steve Hoffman, Former Chair, MA Cannabis Control Commission
- Dr. Stephen Lankenau, Professor and Director of the Medical Cannabis
Research Center, Drexel University
- Dr. Bill McLay, Lead Medical Professional, Ethos Cannabis
- Potency, Policy, and Public Health – Rethinking THC Limits
- Moderator: Greg Garber, PharmD, Thomas Jefferson University

Panelists:

- Emily Hajjar, PharmD, Jefferson College of Pharmacy
- Patrick LaRose, VP of Production, Ethos Cannabis
- Mallory Paul, VP of Commercial Development, ACT Labs

“As a physician and researcher, I’ve seen firsthand how important it is to
have evidence-based conversations around cannabis,” said Dr. Brooke
Worster, Chief Medical Officer at Ethos Cannabis and Medical Director at
Thomas Jefferson University. “Our goal is to foster real-world
understanding of how cannabis can complement traditional care, especially
as we face overlapping public health crises like opioid misuse and chronic
pain.”
About Ethos Cannabis

Ethos Cannabis is a multistate operator with operations in Pennsylvania,
Massachusetts, and Ohio. Ethos boasts four brands in its portfolio, Natural
Selections (MA & PA), Eleven (MA & PA), Headliners (MA), and Meigs County
(OH). The platform serves mainstream consumers while expanding the health
and wellness market through relationships with Thomas Jefferson University
and other academic medical institutions and strategic partnerships.